We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
News and Views |

Mouse Molecular Genetic Technologies Promise for Psychiatric Research

Laurence H. Tecott, MD, PhD; Jeanne M. Wehner, PhD
Arch Gen Psychiatry. 2001;58(11):995-1004. doi:10.1001/archpsyc.58.11.995.
Text Size: A A A
Published online


Recent advances in mammalian genomics are providing unprecedented opportunities to identify genes that influence neural systems relevant to psychiatric illnesses. As a genetically tractable mammalian species in which complex behaviors may be modeled, mice have been the focus of much attention for examining relationships between genes and behavior. Many investigators are pursuing experimental strategies in which the functions of known genes are examined by studying the impact of their manipulation in mice. These studies are providing important information regarding genetic influences on behavior, as well as animal models relevant to human disease processes. Additional powerful genetic strategies have recently been initiated to search broadly for genes that influence particular clinically relevant behavioral traits. These approaches promise to uncover a large number of novel genetic influences on neuronal pathways that regulate behavior. In this review, mouse molecular genetic techniques are described and illustrative examples of their application to neurobehavioral processes relevant to clinical disorders are provided. Future directions in technology development that promise to further enhance the utility of these approaches for translational research are also described.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?


Place holder to copy figure label and caption
Figure 1.

Schematic representations of transgenic and gene targeting procedures. A, To generate transgenic mice, fertilized eggs are collected and a transgenic DNA construct is microinjected into a pronucleus. The construct commonly contains a gene of interest linked to promoter sequences designed to direct gene expression to cell types of interest. The injected eggs are surgically transferred into the oviducts of surrogate mothers. Transmission of the transgene to the offspring is commonly determined by Southern blot analysis of DNA. B, To generate mice with targeted mutations, DNA targeting constructs are introduced into embryonic stem (ES) cells, which are subsequently screened for gene targeting events. Targeted ES cells are microinjected into mouse embryos, which are subsequently surgically transferred into the uteri of surrogate mothers. Chimeric mice containing a mixture of cells derived from the host embryo and the injected ES cells are bred with wild-type mice. Germ line transmission of the mutation is assessed in the offspring.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Schematic representations of quantitative trait loci analysis and N-ethyl-N-nitrosourea (ENU) mutagenesis. A, Representative chromosomes are shown from 2 inbred strains, F1 hybrids, and F2 generations that have differing polymorphisms at chromosomal locations A, B, and C. These polymorphisms can be detected by gel electrophoresis. The mice of the F2 generation are tested on a behavioral task, and the distribution of their behavioral scores is examined. A genome scan of the DNA from high and low responders is performed, and the possible association of the BB/CC and bb/cc genotypes is illustrated to localize a quantitative trait locus (QTL). B, A scheme for detection of dominant mutations. ENU mutagenesis is performed by treating male mice with ENU and then breeding them to the G1 generation. G1 mice undergo behavioral testing for a phenotype of interest. Extreme responders are examined to confirm an association between an induced mutation and the behavioral phenotype.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

21 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles